Clinical trial
Comparison Of Two Corticosteroid Dosing Regimens For Prevention Of Corneal Transplant Rejection Episodes After Descemet's Membrane Endothelial Keratoplasty
NCT01448213 is registered in ClinicalTrials.gov with Price Vision Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison Of Two Corticosteroid Dosing Regimens For Prevention Of Corneal Transplant Rejection Episodes After Descemet's Membrane Endothelial Keratoplasty
- Lead sponsor
- Price Vision Group
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- October 31, 2011
- Completion date
- January 31, 2014
- Enrollment
- 264 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
bullous keratopathy, fuchs' dystrophy